AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.

Shares of Viking Therapeutics VKTX gained more than 11% on Wednesday after the company announced that it had signed a broad ...

Buyers Flock to Big Broad Dramas, and 9 Other London Screenings, Mip London Trends John Hopewell, Alex Ritman, Naman Ramachandran, Leo Barraclough and Jamie Lang February 28, 2025 at 6:45 AM ...

A White House official confirmed that a draft of the agreement includes broad language Ukraine pushed for referencing security guarantees, stating that the U.S. “supports” its effort to ...

Eli Lilly said it will invest at least $27 billion ... with hopes to deliver drugs from its broad pipeline of products for cancer, Alzheimer's disease and other conditions. Ricks said the company ...

Hence, even as the broad market sentiments have turned cautious ... return to the NVO to pick up the pieces, I still think that Eli Lilly's market share gains and production advantages should ...

Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells, as the pharma giant seeks to draw patients away from ...